Pregnancy and childbirth are usually filled with anticipation and hope. Modern obstetrics has dramatically improved the ...

A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside ...

Background: Patients with a transient ischemic attack (TIA) or minor stroke have an increased risk of subsequent stroke that persists for at least 10 years. We aimed to identify prognostic factors ...

Asundexian reduced ischemic stroke risk without increasing major bleeding in the OCEANIC-STROKE study, meeting primary efficacy and safety endpoints. The study included 12,327 patients with acute ...

There is a common misconception that ischemic limb necrosis results only from thrombosis or thromboembolism involving limb arteries, with loss of arterial pulses. Yet ischemic limb gangrene can also ...

A massive report on the world’s health highlights the impact cardiovascular disease continues to have in all regions of the globe, with ischemic heart disease accounting for 10 million deaths and ...

Each year in the United States 200,000–500,00bstract: 500,000 people have a transient ischemic attack (TIA). These episodes of brief neurologic deficits were thought to be fairly benign, but this view ...

Life Recovery Systems (LRS) has received an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) for testing of the ThermoSuit System (TSS) in a pivotal trial of ...

An increased risk for ischemic optic neuropathy may be associated with formulation- and dose-dependent GLP-1 receptor agonist use.

Acute renal failure is defined as a rapid decrease in the glomerular filtration rate, occurring over a period of minutes to days. Because the rate of production of metabolic waste exceeds the rate of ...